Title |
Efficacy and safety of a modular multi-modal exercise program in prostate cancer patients with bone metastases: a randomized controlled trial
|
---|---|
Published in |
BMC Cancer, December 2011
|
DOI | 10.1186/1471-2407-11-517 |
Pubmed ID | |
Authors |
Daniel A Galvão, Dennis R Taaffe, Prue Cormie, Nigel Spry, Suzanne K Chambers, Carolyn Peddle-McIntyre, Michael Baker, James Denham, David Joseph, Geoff Groom, Robert U Newton |
Abstract |
The presence of bone metastases has excluded participation of prostate cancer patients in exercise intervention studies to date and is also a relative contraindication to supervised exercise in the community setting because of concerns of fragility fracture. However, this group of patients often have developed significant muscle atrophy and functional impairments from prior and continuing androgen deprivation that is exacerbated by subsequent and more intensive interventions such as chemotherapy. The aim of this study is to determine the efficacy and safety of a modular multi-modal exercise program in prostate cancer patients with bone metastases. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 67% |
Australia | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Scientists | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Denmark | 1 | <1% |
Italy | 1 | <1% |
Canada | 1 | <1% |
Unknown | 201 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 36 | 18% |
Student > Bachelor | 31 | 15% |
Researcher | 25 | 12% |
Student > Ph. D. Student | 19 | 9% |
Student > Doctoral Student | 8 | 4% |
Other | 33 | 16% |
Unknown | 53 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 48 | 23% |
Nursing and Health Professions | 32 | 16% |
Sports and Recreations | 27 | 13% |
Biochemistry, Genetics and Molecular Biology | 6 | 3% |
Psychology | 5 | 2% |
Other | 21 | 10% |
Unknown | 66 | 32% |